<html><body><h2>Case: 2022456</h2><h3> CDS Time: 1956-08-31</h3>
<patient name=2022456>
56.0 year old Black_Non-Hispanic Female
<p><b>Lab & Note Entry Values:</b> <table>
<b><tr><td width="200">Lab</td><td width="200">Value</td><td width="200">Date</td></tr></b>
<tr><td width="200">Age</td><td width="200">56</td><td width="200">1970-1-1</td></tr>
<tr><td width="200">Calcium</td><td width="200">10</td><td width="200">1956-8-31</td></tr>
<tr><td width="200">Alkaline_phosphatase</td><td width="200">74</td><td width="200">1955-12-23</td></tr>
<tr><td width="200">Phosphorus</td><td width="200">4</td><td width="200">1955-11-18</td></tr>
<tr><td width="200">LDL_Cholesterol</td><td width="200">77</td><td width="200">1955-12-3</td></tr>
<tr><td width="200">Chloride</td><td width="200">107.0</td><td width="200">1956-8-31</td></tr>
<tr><td width="200">HDL_Cholesterol</td><td width="200">48</td><td width="200">1955-12-3</td></tr>
<tr><td width="200">Diastolic_BP</td><td width="200">77</td><td width="200">1956-8-31</td></tr>
<tr><td width="200">BNP</td><td width="200">265</td><td width="200">1955-12-3</td></tr>
<tr><td width="200">Weight</td><td width="200">145</td><td width="200">1956-8-31</td></tr>
<tr><td width="200">HbA1C</td><td width="200">6</td><td width="200">1955-11-12</td></tr>
<tr><td width="200">Triglycerides</td><td width="200">97</td><td width="200">1955-12-3</td></tr>
<tr><td width="200">Total_Cholesterol</td><td width="200">148</td><td width="200">1955-12-3</td></tr>
<tr><td width="200">SGOT</td><td width="200">18</td><td width="200">1955-12-23</td></tr>
<tr><td width="200">Systolic_BP</td><td width="200">160</td><td width="200">1956-8-31</td></tr>
<tr><td width="200">Total_Bilirubin</td><td width="200">1</td><td width="200">1955-12-23</td></tr>
<tr><td width="200">Height</td><td width="200">65</td><td width="200">1956-8-31</td></tr>
<tr><td width="200">Potassium</td><td width="200">4</td><td width="200">1956-8-31</td></tr>
<tr><td width="200">Cholesterol</td><td width="200">148</td><td width="200">1955-12-3</td></tr>
<tr><td width="200">BUN</td><td width="200">16</td><td width="200">1956-8-31</td></tr>
<tr><td width="200">HCT</td><td width="200">40</td><td width="200">1956-8-27</td></tr>
<tr><td width="200">HGB</td><td width="200">14</td><td width="200">1956-8-27</td></tr>
<tr><td width="200">Sodium</td><td width="200">139</td><td width="200">1956-8-31</td></tr>
<tr><td width="200">Albumen</td><td width="200">3</td><td width="200">1955-12-23</td></tr>
<tr><td width="200">Creatinine</td><td width="200">1.0</td><td width="200">1956-8-31</td></tr>
<tr><td width="200">Glycosylated_Hemoglobin</td><td width="200">6</td><td width="200">1955-11-12</td></tr>
<tr><td width="200">Pulse</td><td width="200">64</td><td width="200">1956-8-31</td></tr>
<tr><td width="200">PLT</td><td width="200">224</td><td width="200">1956-8-31</td></tr>
<tr><td width="200">WBC</td><td width="200">10</td><td width="200">1955-12-28</td></tr>
<tr><td width="200">eGFR</td><td width="200">41</td><td width="200">1955-12-3</td></tr>
<tr><td width="200">SGPT</td><td width="200">31</td><td width="200">1955-12-23</td></tr>
<tr><td width="200">Race</td><td width="200">Black_Non-Hispanic</td><td width="200"></td></tr>
<tr><td width="200">Sex</td><td width="200">Female</td><td width="200"></td></tr>
<tr><td width="200">Cardiomyopathy</td><td width="200"></td><td width="200">1956-5-18</td></tr>
<tr><td width="200">Disorders Lipid Metabolism</td><td width="200"></td><td width="200">1955-12-3</td></tr>
<tr><td width="200">Occulusion of cerebral arteries</td><td width="200"></td><td width="200">1956-8-26</td></tr>
<tr><td width="200">Hypertension</td><td width="200"></td><td width="200">1956-5-18</td></tr>
<tr><td width="200">Intracranial hemorrhage</td><td width="200"></td><td width="200">1956-8-26</td></tr>
<tr><td width="200">Heart_Failure</td><td width="200"></td><td width="200">1955-11-13</td></tr>
<tr><td width="200">Hyperlipidemia</td><td width="200"></td><td width="200">1955-12-3</td></tr>
<tr><td width="200">Myocardial_Infarction</td><td width="200"></td><td width="200">1955-11-18</td></tr>
</table>
<p><b>Medications:</b> aspirin(81.0) labetalol(120.0) clonidine(0.0) simvastatin(20.0) atenolol(12.5) lisinopril(10.0) hydrochlorothiazide(25.0) hydralazine(60.0) carvedilol(50.0) lovastatin(0.0) furosemide(0.0) Insulin(0.04) 
<p><b>Problems:</b> <table>
<tr><td width="200"><b>Problem Class</b></td><td width="200"><b>First/Last Dates Reported</b></td><td width="200"></td></tr>
<tr><td width="200">Isolated_Systolic_Hypertension</td>
<td width="200"></td>
<td width="200"> Isolated Systolic Hypertension[Treatment_Systolic_BP(160/null) && Treatment_Diastolic_BP(77/null)]()</td></tr>
<tr><td width="200">Target_Organ_Damage_Clinical_Cardiovascular_Disease</td>
<td width="200"></td>
<td width="200"> TOD/CCD[presence of myocardial infarction]()</td></tr>
<tr><td width="200">Isolated_Systolic_Hypertension K >=3.5</td>
<td width="200"></td>
<td width="200"> Isolated Systolic Hypertension[presence of isolated systolic hypertension && Potassium(4.4/1956-8-31)]()</td></tr>
<tr><td width="200">Heart Failure and BP not controlled</td>
<td width="200"></td>
<td width="200"> Heart Failure[presence of heart failure && BP not adequately controlled based on most recent BPTreatment_Systolic_BP(160/null)]()</td></tr>
<tr><td width="200">MI_with_high_BP</td>
<td width="200"></td>
<td width="200"> Myocardial Infarction[presence of MI && Treatment_Systolic_BP(160/null)]()</td></tr>
<tr><td width="200">ISH on HCTZ and BP not controlled</td>
<td width="200"></td>
<td width="200"> Isolated Systolic Hypertension[presence of isolated systolic hypertension && presence of HCTZ && BP not adequately controlled based on most recent BPTreatment_Systolic_BP(160/null)]()</td></tr>
<tr><td width="200">MI (BP not controlled)</td>
<td width="200"></td>
<td width="200"> Myocardial Infarction[BP not adequately controlled based on most recent BPTreatment_Systolic_BP(160/null) && presence of myocardial infarction]()</td></tr>
<tr><td width="200">Major Cardiovascular Risk Factor</td>
<td width="200"></td>
<td width="200"> Major Cardiovascular Risk Factor[Sex(Female) && Age(56.0/1970-1-1)]()</td></tr>
<tr><td width="200">Dyslipidemia Lab or ICD9</td>
<td width="200"></td>
<td width="200"> Dyslipidemia Lab or ICD9[presence of lipid disorder ICD9]()</td></tr>
<tr><td width="200">CKD by eGFR</td>
<td width="200"></td>
<td width="200"> CKD by eGFR[eGFR(41.0/1955-12-3)]()</td></tr>
<tr><td width="200">CKD by eGFR or ICD9 codes</td>
<td width="200"></td>
<td width="200"> CKD[eGFR(41.0/1955-12-3)]()</td></tr>
<tr><td width="200">On meds & Presence of strong contraindication to HCTZ or using bad drug partner</td>
<td width="200"></td>
<td width="200"> Hypertension[taking furosemide && Antihypertensive_Agents]()</td></tr>
<tr><td width="200">Active prescription for thiazide</td>
<td width="200"></td>
<td width="200"> active prescription for thiazide[presence of thiazide diuretics]()</td></tr>
<tr><td width="200">active prescription for furosemide</td>
<td width="200"></td>
<td width="200"> active prescription for furosemide[taking furosemide]()</td></tr>
<tr><td width="200">on >= 1 med</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">taking >= 2 anti hypertensive meds</td>
<td width="200"></td>
<td width="200"> Combination therapy for HTN[Antihypertensive_Agents]()</td></tr>
<tr><td width="200">On 1 drug and there exists contraindicated drug or a compelling drug not given</td>
<td width="200"></td>
<td width="200"> On 1 drug and there exists contraindicated drug or a compelling drug not given[there exists a compellingly indicated drug that is not already given]()</td></tr>
<tr><td width="200">Hypertension with MI and K>=3.5</td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(4.4/1956-8-31) && presence of MI]()</td></tr>
<tr><td width="200">Absence of Stage D HF</td>
<td width="200"></td>
<td width="200"> Absence of Stage D HF[Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF)]()</td></tr>
<tr><td width="200">CCS-7.4</td>
<td width="200">1956-08-26</td>
<td width="200"> Intracranial hemorrhage()</td></tr>
<tr> <td width="200"></td>
<td width="200">1956-08-26</td>
<td width="200"> Occulusion of cerebral arteries()</td></tr>
<tr><td width="200">CCS-7.2</td>
<td width="200">1955-11-18</td>
<td width="200"> Myocardial_Infarction()</td></tr>
<tr> <td width="200"></td>
<td width="200">1955-11-13</td>
<td width="200"> Heart_Failure()</td></tr>
<tr> <td width="200"></td>
<td width="200">1956-05-18</td>
<td width="200"> Cardiomyopathy()</td></tr>
<tr><td width="200">Hypertension_Inclusive</td>
<td width="200">1956-05-18</td>
<td width="200"> Hypertension()</td></tr>
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(4.4/1956-8-31) && presence of MI]()</td></tr>
<tr><td width="200">Metabolic&Nutritional_Diseases</td>
<td width="200">1955-12-03</td>
<td width="200"> Disorders Lipid Metabolism()</td></tr>
<tr><td width="200">Hypertension_Defined</td>
<td width="200"></td>
<td width="200"> Hypertension with MI and K>=3.5[Potassium(4.4/1956-8-31) && presence of MI]()</td></tr>
<tr><td width="200"> <b>Others</b></td>
<td width="200">1955-12-03</td>
<td width="200"> Hyperlipidemia()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Race()
<tr> <td width="200"></td>
<td width="200"></td>
<td width="200"> Sex()
</table><p>
</patient>
<h1 align="center">ATHENA Heart Failure Guideline</h1>
<b>Patient classification:</b> <ul>
<li>ATHENA Heart Failure Guideline: true[because <i> Eligibility criteria </i> evaluate to <b>true</b><i>(Not Stage D HF (refractory end stage HF)Stage D HF (refractory end stage HF))</i>]
</ul>
<b>Scenario choice:</b> Stage C HF
<p>
<b>Goal:</b> LDL< 160 mg/dL(0-1 risk factors)
<p><b>Reached goal?</b> achieved(LDL_Cholesterol(77.0/1955-12-3))
<p>
<b>Goal:</b> SBP < 140 and DBP < 90(absence of diabetes mellitus)
<p><b>Reached goal?</b> failed(Treatment_Systolic_BP(160/null))
<p><b>Messages by Types</b>
<ul>
<li><b>Class II a</b>
<ul>
<li>Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)
</ul>
<li><b>Class I</b>
<ul>
<li>Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
<li>Coronary revascularization should be recommended in appropriate patients without symptoms of HF in accordance with contemporary guidelines (see ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina).
</ul>
<li><b>Class III</b>
<ul>
<li>Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
</ul>
</ul>
<p><b>Action Choices</b>
<ul>
<li><b>Stage C HF</b><br>
<ul>
</ul>
<li><b> </b><br>
<ul>
<li><b>General Recommendations <font color=FF0000>preferred</font></b>(strict rule-in condition<i> HF ICD9 code OR( signs and structural abnormality)</i> evaluate to <b> true</b> because <i>Presence of HF</i>)])
Exercise training is beneficial as an adjunctive approach to improve clinical status in ambulatory patients with current or prior symptoms of HF and reduced LVEF. (Level of Evidence: B)
Maximal exercise testing with or without measurement of respiratory gas exchange is reasonable to facilitate prescription of an appropriate exercise program for patients presenting with HF. (Level of Evidence: C)

<li><b>Referrals <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])
Class I
<li><b>Stage B HF action <font color=FF0000>preferred</font></b>(strict rule-in condition<i> true</i> evaluate to <b> true</i>)])

Use of nutritional supplements to treat structural heart disease or to prevent the development of symptoms of HF is NOT recommended.
Coronary revascularization should be recommended in appropriate patients without symptoms of HF in accordance with contemporary guidelines (see ACC/AHA/ACP-ASIM Guidelines for the Management of Patients With Chronic Stable Angina).
</ul>
</ul>
<b>Considerations for adding drug: </b><ul><li>aldosterone antagonist<ul><li>preference: neutral<li>No comment</ul><li>hydralazine and nitrates<ul><li>preference: neutral<li>No comment</ul><li>Beta blocker for stage C heart failure(Carvedilol)<ul><li>Already being used<li>preference: ruled out</ul><li>Beta blocker Stage C with MI(Carvedilol)<ul><li>Already being used<li>preference: ruled out</ul></ul><b>Considerations for adding drug: </b><ul><li>ARB<ul><li>preference: neutral<li>No comment</ul><li>digoxin<ul><li>preference: neutral<li>No comment</ul><li>Ace_Inhibitor(Captopril, Lisinopril, Enalapril)<ul><li>Already being used<li><font color=FF0000>Compelling indications:  Myocardial_Infarction(Myocardial_Infarction) </font><li>preference: ruled out</ul><li>Beta blocker stage B post MI(Carvedilol)<ul><li>Already being used<li>preference: ruled out</ul><li>Beta Blocker Stage B no MI<ul><li>Already being used<li>preference: ruled out</ul><li>NDHP CCB<ul><li>Contraindications:  Heart_Failure(Cardiomyopathy, Heart_Failure)  Myocardial_Infarction(Myocardial_Infarction) <li>preference: ruled out</ul></ul></body></html>